|
1
|
He W, Tang B, Yang D, et al:
Double-positive expression of high-mobility group box 1 and
vascular endothelial growth factor C indicates a poorer prognosis
in gastric cancer patients. World J Surg Oncol. 11:1612013.
View Article : Google Scholar
|
|
2
|
Zhang YZ, Zhang LH, Gao Y, et al:
Discovery and validation of prognostic markers in gastric cancer by
genome-wide expression profiling. World J Gastroenterol.
17:1710–1717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jia YF, Xiao DJ, Ma XL, et al:
Differentiated embryonic chondrocyte-expressed gene 1 is associated
with hypoxia-inducible factor 1alpha and Ki67 in human gastric
cancer. Diagn Pathol. 8:372013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jin J, Jin T, Quan M, Piao Y and Lin Z:
Ezrin overexpression predicts the poor prognosis of gastric
adenocarcinoma. Diagn Pathol. 7:1352012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sotoudeh K, Hashemi F, Madjd Z,
Sadeghipour A, Molanaei S and Kalantary E: The clinicopathologic
association of c-MET overexpression in Iranian gastric carcinomas;
an immunohistochemical study of tissue microarrays. Diagn Pathol.
7:572012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grisendi S, Mecucci C, Falini B and
Pandolfi PP: Nucleophosmin and cancer. Nat Rev Cancer. 6:493–505.
2006. View
Article : Google Scholar
|
|
7
|
Khandelwal N, Simpson J, Taylor G, Rafique
S, Whitehouse A, Hiscox J and Stark LA: Nucleolar NF-kappaB/RelA
mediates apoptosis by causing cytoplasmic relocalization of
nucleophosmin. Cell Death Differ. 18:1889–1903. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin CY, Liang YC and Yung BY:
Nucleophosmin/B23 regulates transcriptional activation of E2F1 via
modulating the promoter binding of NF-kappaB, E2F1 and pRB. Cell
Signal. 18:2041–2048. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nozawa Y, Van Belzen N, Van der Made AC,
Dinjens WN and Bosman FT: Expression of nucleophosmin/B23 in normal
and neoplastic colorectal mucosa. J Pathol. 178:48–52. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yun JP, Miao J, Chen GG, et al: Increased
expression of nucleophosmin/B23 in hepatocellular carcinoma and
correlation with clinicopathological parameters. Br J Cancer.
96:477–484. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Subong EN, Shue MJ, Epstein JI, Briggman
JV, Chan PK and Partin AW: Monoclonal antibody to prostate cancer
nuclear matrix protein (PRO:4–216) recognizes nucleophosmin/B23.
Prostate. 39:298–304. 1999.
|
|
12
|
Tsui KH, Cheng AJ, Chang Pe, Pan TL and
Yung BY: Association of nucleophosmin/B23 mRNA expression with
clinical outcome in patients with bladder carcinoma. Urology.
64:839–844. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y: The ARF-B23 connection:
implications for growth control and cancer treatment. Cell Cycle.
3:259–262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mascaux C, Bex F, Martin B, et al: The
role of NPM, p14arf and MDM2 in precursors of bronchial squamous
cell carcinoma. Eur Respir J. 32:678–686. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tanaka M, Sasaki H, Kino I, Sugimura T and
Terada M: Genes preferentially expressed in embryo stomach are
predominantly expressed in gastric cancer. Cancer Res.
52:3372–3377. 1992.PubMed/NCBI
|
|
16
|
Muskett FW, May FE, Westley BR and Feeney
J: Solution structure of the disulfide-linked dimer of human
intestinal trefoil factor (TFF3): the intermolecular orientation
and interactions are markedly different from those of other dimeric
trefoil proteins. Biochemistry. 42:15139–15147. 2003. View Article : Google Scholar
|
|
17
|
Katoh M: Trefoil factors and human gastric
cancer (Review). Int J Mol Med. 12:3–9. 2003.
|
|
18
|
Meyer zum Buschenfelde D, Hoschutzky H,
Tauber R and Huber O: Molecular mechanisms involved in TFF3
peptide-mediated modulation of the E-cadherin/catenin cell adhesion
complex. Peptides. 25:873–883. 2004.PubMed/NCBI
|
|
19
|
Chen YH, Lu Y, De Plaen IG, Wang LY and
Tan XD: Transcription factor NF-kappaB signals antianoikic function
of trefoil factor 3 on intestinal epithelial cells. Biochem Biophys
Res Commun. 274:576–582. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leung WK, Yu J, Chan FK, et al: Expression
of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas,
intestinal metaplasia, and non-neoplastic gastric tissues. J
Pathol. 197:582–588. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamachika T, Werther JL, Bodian C, et al:
Intestinal trefoil factor: a marker of poor prognosis in gastric
carcinoma. Clin Cancer Res. 8:1092–1099. 2002.PubMed/NCBI
|
|
22
|
Zhou F, Qiu W, Sun L, et al: Clinical
significance of nucleophosmin/B23 and human epidermal growth factor
receptor 2/neu expressions in gastric cancers. APMIS. 121:582–591.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu CC, Yue L, Wei HJ, et al: Significance
of TFF3 protein and Her-2/neu status in patients with gastric
adenocarcinoma. Pathol Res Pract. 209:479–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu D, Huang Y, Geng Q, Guan Y, Li Y, et
al: Effect of lymph node number on survival of patients with lymph
node-negative gastric cancer according to the 7th edition UICC TNM
system. PLoS One. 7:e386812012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ding A, Zhao W, Shi X, et al: Impact of
NPM, TFF3 and TACC1 on the prognosis of patients with primary
gastric cancer. PLoS One. 8:e821362013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsui KH, Juang HH, Lee TH, Chang PL, Chen
CL and Yung BY: Association of nucleophosmin/B23 with bladder
cancer recurrence based on immunohistochemical assessment in
clinical samples. Acta Pharmacol Sin. 29:364–370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meng JR, Tang HZ, Zhou KZ, Shen WH and Guo
HY: TFF3 and survivin expressions associate with a lower survival
rate in gastric cancer. Clin Exp Med. 13:297–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dhar DK, Wang TC, Tabara H, et al:
Expression of trefoil factor family members correlates with patient
prognosis and neoangiogenesis. Clin Cancer Res. 11:6472–6478. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tobita H, Kajino K, Inami K, et al: Gene
expression profile of DNA binding protein A transgenic mice. Int J
Oncol. 29:673–679. 2006.PubMed/NCBI
|
